by Editorial Team | 17 Nov, 2023 | NEWS, TheraPPI
November 17, 2023 – Lyon, France The Fondation Genevoise pour l’Innovation Technologique (“FONGIT”) has granted a FIF seed loan of CHF100 000 to TheraPPI Bioscience which is currently being registered in the Canton of Geneva (Switzerland) for their innovative...
by Editorial Team | 9 Nov, 2023 | NEWS, TheraPPI
TheraPPI Bioscience SAS is proud to announce that it has been awarded the French Tech Seed label, a recognition reserved for DeepTech startups less than three years old. This distinction acknowledges TheraPPI’s remarkable technological innovation, astute...
by Editorial Team | 7 Jun, 2023 | LinkedIn, NEWS, TheraPPI
June 7, 2023 “Quite excited to present TheraPPI at BioValley Basel on 19 June 2023!” said Luc Otten Chief Executive Officer of TheraPPI Bioscience (“TheraPPI”), a preclinical biotechnology company developing a portfolio of small molecules...
by Editorial Team | 17 May, 2023 | LinkedIn, NEWS, TheraPPI
May 17, 2023 “”We are honoured to have been selected Tech Tour among innovative companies to present in Paris on 1st and 2nd June at FTI 2023. This is an exciting opportunity to present TheraPPI.” said Luc Otten Chief Executive Officer of TheraPPI...
by Editorial Team | 12 Apr, 2023 | LinkedIn, NEWS, TheraPPI
April 12, 2023 “”We’re are proud to be among the Finalists of the 2023 >>venture>> Finalists! Venture.ch is a highly competitve challenge for startups and selects highly promising start-ups.” said Luc Otten Chief Executive Officer of...